These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3472771)

  • 21. A chimeric, ligand-binding v-erbB/EGF receptor retains transforming potential.
    Riedel H; Schlessinger J; Ullrich A
    Science; 1987 Apr; 236(4798):197-200. PubMed ID: 3494307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the receptor kinase domain of the trk oncogene by recombination with two different cellular sequences.
    Kozma SC; Redmond SM; Fu XC; Saurer SM; Groner B; Hynes NE
    EMBO J; 1988 Jan; 7(1):147-54. PubMed ID: 2966065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural features that specify tyrosine kinase activity deduced from homology modeling of the epidermal growth factor receptor.
    Knighton DR; Cadena DL; Zheng J; Ten Eyck LF; Taylor SS; Sowadski JM; Gill GN
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5001-5. PubMed ID: 8389462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular cloning and expression of an additional epidermal growth factor receptor-related gene.
    Plowman GD; Whitney GS; Neubauer MG; Green JM; McDonald VL; Todaro GJ; Shoyab M
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):4905-9. PubMed ID: 2164210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel human gene closely related to the abl proto-oncogene.
    Kruh GD; King CR; Kraus MH; Popescu NC; Amsbaugh SC; McBride WO; Aaronson SA
    Science; 1986 Dec; 234(4783):1545-8. PubMed ID: 3787260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of intrinsic protein tyrosine kinase in function and metabolism of the epidermal growth factor receptor.
    Gill GN; Chen WS; Lazar CS; Glenney JR; Wiley HS; Ingraham HA; Rosenfeld MG
    Cold Spring Harb Symp Quant Biol; 1988; 53 Pt 1():467-76. PubMed ID: 3254778
    [No Abstract]   [Full Text] [Related]  

  • 27. Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo.
    Yokota J; Yamamoto T; Toyoshima K; Terada M; Sugimura T; Battifora H; Cline MJ
    Lancet; 1986 Apr; 1(8484):765-7. PubMed ID: 2870269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of two new human oncogenes.
    Birchmeier C; Young D; Wigler M
    Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 2():993-1000. PubMed ID: 3472773
    [No Abstract]   [Full Text] [Related]  

  • 29. A basic residue C-terminal to tyrosine compromises its viability as a tyrosine kinase target.
    Keane NE; Quirk PG; Levine BA; Chavanieu A; Calas B; Gao Y; Wei L; Ellis L
    Biochem Soc Trans; 1995 May; 23(2):192S. PubMed ID: 7672214
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular cloning and analysis of cDNA encoding the murine c-yes tyrosine protein kinase.
    Klages S; Adam D; Eiseman E; Fargnoli J; Dymecki SM; Desiderio SV; Bolen JB
    Oncogene; 1993 Mar; 8(3):713-9. PubMed ID: 8437854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homology among oncogenes.
    Van Beveren C; Verma IM
    Curr Top Microbiol Immunol; 1986; 123():73-98. PubMed ID: 3004831
    [No Abstract]   [Full Text] [Related]  

  • 32. Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses.
    Lupu R; Colomer R; Kannan B; Lippman ME
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2287-91. PubMed ID: 1347947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amplified cellular oncogenes in neoplasms of the human central nervous system.
    Fuller GN; Bigner SH
    Mutat Res; 1992 May; 276(3):299-306. PubMed ID: 1374522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of tyrosine kinase inhibitor, erbstatin, on cell growth and growth-factor/receptor gene expression in human gastric carcinoma cells.
    Takekura N; Yasui W; Kyo E; Yoshida K; Kameda T; Kitadai Y; Abe K; Umezawa K; Tahara E
    Int J Cancer; 1991 Apr; 47(6):938-42. PubMed ID: 1849125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification.
    Wong AJ; Bigner SH; Bigner DD; Kinzler KW; Hamilton SR; Vogelstein B
    Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6899-903. PubMed ID: 3477813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiphosphotyrosine antibodies in oncogene and receptor research.
    Stern DF
    Methods Enzymol; 1991; 198():494-501. PubMed ID: 1713286
    [No Abstract]   [Full Text] [Related]  

  • 37. The let-23 gene necessary for Caenorhabditis elegans vulval induction encodes a tyrosine kinase of the EGF receptor subfamily.
    Aroian RV; Koga M; Mendel JE; Ohshima Y; Sternberg PW
    Nature; 1990 Dec 20-27; 348(6303):693-9. PubMed ID: 1979659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A highly conserved tyrosine residue at codon 845 within the kinase domain is not required for the transforming activity of human epidermal growth factor receptor.
    Gotoh N; Tojo A; Hino M; Yazaki Y; Shibuya M
    Biochem Biophys Res Commun; 1992 Jul; 186(2):768-74. PubMed ID: 1323290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical characterization of the protein tyrosine kinase homology domain of the ErbB3 (HER3) receptor protein.
    Sierke SL; Cheng K; Kim HH; Koland JG
    Biochem J; 1997 Mar; 322 ( Pt 3)(Pt 3):757-63. PubMed ID: 9148746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A tyrosine kinase profile of prostate carcinoma.
    Robinson D; He F; Pretlow T; Kung HJ
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5958-62. PubMed ID: 8650201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.